Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Inside job: NC inmates accused of running phone scams targeting families for fake bail payments
Recommended
Summer maintenance tips: Do these things indoors and out to keep your home cool in summer heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
124.86
-0.88 (-0.70%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Jul 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
46
47
Next >
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
May 21, 2024
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings.
Via
Benzinga
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
May 20, 2024
Corrections are a part of investing and investors would be smart to have these three S&P 500 stocks to buy when the inevitable happens.
Via
InvestorPlace
Topics
Stocks
These Dividend Stocks Are an Investor's Best Friend
May 16, 2024
These two healthcare stocks are well-known for their top-tier dividend programs.
Via
The Motley Fool
Best Foundational Stocks
May 15, 2024
Building the foundation of investors portfolio with the best US foundational stocks by sector.
Via
Talk Markets
Looking At Abbott Laboratories's Recent Unusual Options Activity
May 14, 2024
Via
Benzinga
How Is The Market Feeling About Abbott Laboratories?
May 03, 2024
Via
Benzinga
What the Options Market Tells Us About Abbott Laboratories
May 01, 2024
Via
Benzinga
Behind the Scenes of Abbott Laboratories's Latest Options Trends
April 18, 2024
Via
Benzinga
Catalyst's New CEO Has Big Ideas For The Small Biotech
May 10, 2024
Richard Daly is Catalyst Pharmaceuticals' second CEO, taking over for Patrick McEnany, who retired last year.
Via
Investor's Business Daily
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling
May 09, 2024
Via
Benzinga
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
May 08, 2024
Check out these healthcare stocks for some healthy payouts.
Via
The Motley Fool
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
May 01, 2024
Investors should look for opportunities to buy these leading healthcare companies, each of which posted strong Q1 results.
Via
InvestorPlace
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
April 30, 2024
Via
AB Newswire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
April 30, 2024
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Via
MarketBeat
7 Defensive Stocks Built to Withstand the Market’s Worst Storms
April 30, 2024
With the market operating under a worrisome backdrop, investors may want to target certain defensive stocks to buy.
Via
InvestorPlace
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
April 28, 2024
These companies aren't in danger of becoming has-beens.
Via
The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
April 28, 2024
One thing is for sure: Dividend seekers can't go wrong with either.
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
You'll get dividends and more with these great stocks.
Via
The Motley Fool
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
April 25, 2024
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.
Via
Talk Markets
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.
Via
InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
April 22, 2024
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.
Via
InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
April 19, 2024
The Nasdaq and S&P 500 tumbled below their 50-day lines.
Via
Investor's Business Daily
Topics
Stocks
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
April 17, 2024
A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as...
Via
Benzinga
Topics
Bonds
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
April 17, 2024
ABT earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024
April 17, 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Abbott Laboratories Outlook is Healthy: Buy the Dip
April 17, 2024
Abbott Laboratories had a steady quarter, producing growth, better-than-expected earnings, and raising the guidance. Analysts see the stock moving higher.
Via
MarketBeat
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
April 17, 2024
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth.
Via
Talk Markets
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings
April 17, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
April 17, 2024
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but shares fell.
Via
Investor's Business Daily
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
April 17, 2024
Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO...
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
46
47
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.